Get startedLog in
    Picture of Sunrest Lifescience logo

    SUNREST — Sunrest Lifescience Income Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapTurnaround
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Sunrest Lifescience, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    2025
    March 31st
    2026
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:PROSPECTUSPROSPECTUSARSARSARS
    Standards:
    IAS
    IAS
    IAS
    IAS
    IAS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue269246295334708
    Cost of Revenue
    Gross Profit94.397.695133266
    Selling / General / Administrative Expenses
    Depreciation and Amortization
    Other Operating Expenses
    Total Operating Expenses258219287305621
    Operating Profit10.427.78.129.287.3
    Total Net Non Operating Interest Income / Expense
    Gain / Loss on Sale of Assets
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes10.527.45.9326.2101
    Provision for Income Taxes
    Net Income After Taxes7.7720.42.2620.179.9
    Minority Interest
    Net Income Before Extraordinary Items
    Net Income7.7720.42.2620.141.2
    Adjustments to Net Income
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income7.7720.42.2620.141.2
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS1.473.960.5663.895.25
    Dividends per Share